首页 | 本学科首页   官方微博 | 高级检索  
检索        

心脏舒张功能障碍逆转的临床探讨
引用本文:王瑛,崔玉娟,陈玉丽,王照谦,坂本真吾,永井阳子,杨国慧,朴鑫,李峰春,朱丽丽,张新颖,张哿,马临庆,王超,易威,林阳.心脏舒张功能障碍逆转的临床探讨[J].心血管康复医学杂志,2012(2):162-164.
作者姓名:王瑛  崔玉娟  陈玉丽  王照谦  坂本真吾  永井阳子  杨国慧  朴鑫  李峰春  朱丽丽  张新颖  张哿  马临庆  王超  易威  林阳
作者单位:大连维特奥国际医院;长春市中心医院;大连医科大学附属第一医院
摘    要:目的:探讨心脏舒张功能障碍的逆转。方法:入选我院舒张功能障碍的病人223例,随机分为常规治疗组,给予丹参滴注液16g,1次/d;磷酸肌酸钠组:在常规治疗组基础上给予磷酸肌酸钠静脉滴注(轻度舒张功能障碍每日给药2.0g,中重度舒张功能障碍给药2.0g,2次/d),并采用彩色多普勒超声心动图观察二尖瓣口舒张早期峰值流速(E)、二尖瓣口舒张晚期峰值流速(A)、二尖瓣环舒张早期速度峰值(Ea)、二尖瓣环舒张晚期速度峰值(Aa),计算E/A值,Ea/Aa值,E/Ea值。连续治疗14d,并根据治疗前后临床症状、体征及彩色多普勒超声心动图各指标改善情况评价疗效。结果:治疗后,与常规治疗组比较,磷酸肌酸钠组患者的症状、体征显效率(53.8%比98.2%,62.5%比92.0%),综合疗效的显效率(11.43%比82.97%),E/A值(0.82±0.15)比(1.20±0.24)]、Ea/Aa值(0.88±0.23)比(1.56±0.31)]显著提高,E/Ea值(9.89±3.15)比(5.84±2.12)]显著降低,P均〈0.01。结论:舒张功能障碍早期发现和干预是可以逆转的,磷酸肌酸钠有显著的治疗作用,是逆转舒张功能障碍的首选药物。

关 键 词:心室功能障碍  磷酸肌酸  丹参注射液

Study for reversal of cardiac diastolic dysfunction
WANG Ying,CUI Yu-juan,CHEN Yu-li,WANG Zhao-qian,Shingo Sakamoto,Yoko Nagai,YANG Guo-hui,PIAO Xin,LI Feng-chun,ZHU Li-li,ZHANG Xin-ying,ZHANG Ge,MA Lin-qing,WANG Chao,YI Wei,LIN Yang.Study for reversal of cardiac diastolic dysfunction[J].Chinese Journal of Cardiovascular Rehabilitation Medicine,2012(2):162-164.
Authors:WANG Ying  CUI Yu-juan  CHEN Yu-li  WANG Zhao-qian  Shingo Sakamoto  Yoko Nagai  YANG Guo-hui  PIAO Xin  LI Feng-chun  ZHU Li-li  ZHANG Xin-ying  ZHANG Ge  MA Lin-qing  WANG Chao  YI Wei  LIN Yang
Institution:1//1.Dalian Vitup International Hospital,Dalian,Liaoning,116001,China;2.Central Hospital of Changchun City;3.First Affiliated Hospital of Dalian Medical University
Abstract:Objective: To study the reversal of cardiac diastolic dysfunction.Methods: A total of 223 patients with diastolic dysfunction were enrolled and randomly divided into routine treatment group(received Salvia miltiorrhiza drip infusion 16g,once a day) and creatine phosphate sodium(CP) group.Patients in CP group received CP intraveinous drip based on routine treatment(those with mild diastolic dysfunction received CP 2.0g,once a day;those with moderate or severe diastolic dysfunction received CP 2.0g,twice a day)].Color-coded Doppler echocardiography was used to measure transmitral early diastolic peak flow velocity(E),transmitral late diastolic peak flow velocity(A),early diastolic peak velocity of mitral annulus(Ea),late diastolic peak velocity of mitral annulus(Aa),and E/A,Ea/Aa,E/Ea were calculated.All patients were treated for 14 d and therapeutic effects were evaluated according to improvements of clinical symptoms,signs and indicators in color-coded Doppler echocardiography after treatment.Results: Compared with routine treatment group after treatment,there were significantly increase in excellence rates of clinical symptom(53.8% vs.98.2%),sign(62.5% vs.92.0%),synthetic curative effect(11.43% vs.82.97%)and E/A ratio (0.82±0.15)vs.(1.20±0.24)]、Ea/Aa (0.88±0.23)vs.(1.56±0.31)],and significantly decrease in E/Ea (9.89±3.15)vs.(5.84±2.12)],P<0.01 all in CP group.Conclusion: If recognized and treated early,diastolic dysfunction is reversible.Creatine phosphate sodium has significant therapeutic effects on diastolic dysfunction and is preferred for reversal of diastolic dysfunction.
Keywords:Ventricular dysfunction  Phosphocreatine  Salvia miltiorrhiza injection
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号